Diazoxide provides protection to human myocardium in vitro that is concentration dependent

Annals of Thoracic Surgery

Volumn 77, Issue 1, 2004, Pages 226-232

  Deja, Marek A ^a   Golba, Krzysztof S ^a   Kolowca, Maciej ^a   Widenka, Kazimierz ^a   Biernat, Jolanta ^a   Wos, Stanislaw ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGON; CARBON DIOXIDE; DIAZOXIDE; NORADRENALIN; OXYGEN; TROPONIN I;

ARTICLE; CELL VIABILITY; CHEMICAL REACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CONVALESCENCE; HEART ATRIUM APPENDAGE; HEART ATRIUM CONTRACTILITY; HEART FUNCTION; HEART INJURY; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RIGHT ATRIUM; HEART SURGERY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INOTROPISM; ISOLATION PROCEDURE; MEASUREMENT; OXYGENATION; PRIORITY JOURNAL; PROTEIN SECRETION; RECORDING; REOXYGENATION;

EID: 1642441551     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)01295-5     Document Type: Article

References (26)

1. Gross G.J., Auchampach J.A. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 70:1992;223-233.
2. + channels and myocardial protection. Circ Res. 84:1999;973-979.
3. + channels possible mechanism of cardioprotection . Circ Res. 81:1997;1072-1082.
4. Liu Y., Sato T., O'Rourke B., Marban E. Mitochondrial ATP-dependent potassium channels novel effectors of cardioprotection? Circulation. 97:1998;2463-2469.
5. ATP channels in ischemic cardioprotection. Circulation. 101:2000;2418-2423.
6. 2+ overload in rat cardiac mitochondria. J Physiol. 519:1999;347-360.
7. Laclau M.N., Boudina S., Thambo J.B., et al. Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase. J Mol Cell Cardiol. 33:2001;947-956.
8. ATP channels by diazoxide. Circulation. 104:2001;85-90.
9. Forbes R.A., Steenbergen C., Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res. 88:2001;802-809.
10. ε activation in the mechanism of preconditioning. Am J Physiol Heart Circ Physiol. 283:2002;H440-447.
11. ATP channels role in cardioprotection . Cardiovasc Res. 55:2002;429-437.
12. Ozcan C., Holmuhamedov E.L., Jahangir A., Terzic A. Diazoxide protects mitochondria from anoxic injury implications for myopreservation . J Thorac Cardiovasc Surg. 121:2001;298-306.
13. Ghosh S., Standen N., Galinanes M. Evidence for mitochondrial channels as effectors of human myocardial preconditioning. Cardiovasc Res. 45:2000;339-350.
14. ATP channel opening controls human myocardial preconditioning too much of a good thing? Surgery. 128:2000;368-373.
15. Pomerantz B.J., Robinson T.N., Morrell T.D., Heimbach J.K., Banerjee A., Harken A.H. Selective mitochondrial adenosine-sensitive potassium channel activation is sufficient to precondition human myocardium. J Thorac Cardiovasc Surg. 120:2000;387-392.
16. Toyoda Y., Levitsky S., McCully J.D. Opening of mitochondrial ATP-sensitive potassium channels enhances cardioplegic protection. Ann Thorac Surg. 71:2001;1281-1289.
17. Wakiyama H., Cowan D.B., Toyoda Y., Federman M., Levitsky S., McCully J.D. Selective opening of mitochondrial ATP-sensitive potassium channels during surgically induced myocardial ischemia decreases necrosis and apoptosis. Eur J Cardiothorac Surg. 21:2002;424-433.
18. McCully J.D., Wakiyama H., Cowan D.B., Federman M., Parker R.A., Levitsky S. Diazoxide amelioration of myocardial injury and mitochondrial damage during cardiac surgery. Ann Thorac Surg. 74:2002;2138-2146.
19. Kavelaitis E., Oubenaissa A., Mouas C., Peynet J., Menasche P. Ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na+/H+ exchange inhibition which is the best protective strategy for heart transplants? J Thorac Cardiovasc Surg. 121:2001;155-162.
20. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res. 77:1995;1030-1035.
21. Crestanello J.A., Lingle D.M., Millili J., Whitman G.J. Pyruvate improves myocardial tolerance to reperfusion injury by acting as an antioxidant a chemiluminescence study . Surgery. 124:1998;92-99.
22. Dobsak P., Courderot-Masuyer C., Zeller M., et al. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. J Cardiovasc Pharmacol. 34:1999;651-659.
23. Monti F., Iwashiro K., Picard S., et al. Adenosine triphosphate- dependent potassium channel modulation and cardioplegia-induced protection of human atrial muscle in an in vitro model of myocardial stunning. J Thorac Cardiovasc Surg. 119:2000;842-848.
24. Golba K.S., Deja M.A., Wos S., et al. Reactivity of isolated human right atria to norepinephrine in various disease states. J Physiol Pharmacol. 46:1995;323-328.
25. ATP channels in adenosine enhanced ischemic preconditioning. Am J Physiol Heart Circ Physiol. 279:2000;H2694-2703.
26. ATP channel-independent targets of diazoxide and 5-hydroxydecaonate in the heart. J Physiol. 542:2002;735-741.